Privia Health 2025 Q2 Earnings Misses Targets as Net Income Slips 33.3%

Privia Health (PRVA) reported its fiscal 2025 Q2 earnings on August 7, 2025. The company raised full-year guidance for several metrics but missed earnings expectations, with a sharp decline in EPS and net income.

The results show a mixed performance as the company continues to expand its footprint and refine its business model.

Revenue
Privia Health’s total revenue surged 23.4% year-over-quarter to $521.15 million, driven by strong growth in its fee-for-service (FFS) and capitated revenue streams. FFS-patient care revenue reached $331.46 million, while capitated revenue hit $75.51 million. Shared savings and care management fees also posted gains, contributing $60.02 million and $16.92 million, respectively. Administrative services and other revenue accounted for the remaining portions of the total.

Earnings/Net Income
Despite robust revenue growth, Privia Health’s earnings underperformed. Earnings per share (EPS) declined 33.3% year-over-quarter to $0.02, and net income fell to $3.29 million, a 29.2% drop from $4.64 million in the prior year.

Price Action
Following the earnings release, Privia Health’s stock experienced a downturn, with a 2.45% decline during the latest trading day and a 9.34% drop month-to-date.

Post-Earnings Price Action Review
A backtest of a strategy that buys shares after a revenue increase and holds for 30 days yielded poor results over the past three years, with a return of -32.69%. This significantly underperformed the benchmark return of 51.69%. The strategy recorded a CAGR of -12.53% and a maximum drawdown of 0.00%, highlighting the inherent risks and volatility associated with this approach.

CEO Commentary
CEO Parth Mehrotra emphasized Privia Health’s strong performance, citing 13.8% year-over-year implemented provider growth and 15.2% value-based lives attribution growth. He noted the company’s differentiated model—combining medical groups, risk-bearing, and a tech platform—as a driver of consistent financial performance. Mehrotra expressed confidence in the business model and optimism about growth from new provider signings and operational execution.

Guidance
Privia Health raised its full-year 2025 guidance for Practice Collections, GAAP Revenue, Platform Contribution, and Adjusted EBITDA to above the high end of initial ranges. The company expects over 80% of full-year adjusted EBITDA to convert to free cash flow and anticipates ending 2025 with more than $450 million in cash, assuming no further capital deployment.

Additional News
Recent developments include the company’s $95 million acquisition of an IMS transaction in Arizona, signaling a strategic move to expand its market presence. Privia Health also announced plans to host a conference call on August 7, 2025, to discuss its financial results and future outlook. No major executive changes or dividend announcements were reported within the specified timeframe.